WHITEHOUSE STATION and KENILWORTH, N.J., July 23, 2004 — Merck/Schering-Plough Pharmaceuticals announced today that the U.S. Food and Drug Administration has approved VYTORIN TM (ezetimibe/simvastatin ...
Verywell Health on MSN
Simvastatin vs. atorvastatin: Which is better at lowering cholesterol?
Medically reviewed by Femi Aremu, PharmD Key Takeaways Atorvastatin can lower LDL cholesterol by 50% or more when taken in high doses.Simvastatin can lower LDL cholesterol by up to 50% when taken in ...
Niacin extended-release 500 mg, simvastatin 20 mg; tabs. Simcor combines the HMG-CoA reductase inhibitor, simvastatin, and the nicotinic acid derivative, extended-release niacin (Niaspan, also from ...
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced changes to the prescribing information in the United States for the ...
London, UK - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) is recommending that a combination tablet of fenofibrate ...
LONDON, United Kingdom — The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) is recommending that a combination tablet ...
Simvastatin is a medication for treating high cholesterol. Medicare Part D and Part C plans with drug coverage should, in most cases, cover this drug or an effective alternative. Simvastatin (Zocor) ...
Simvastatin is frequently administered to diabetic patients with hypercholesterolemia. The aim of the study was to investigate the pharmacokinetics of simvastatin and its hydrolysate simvastatin acid ...
The aim of the study is to evaluate the effect of simvastatin in erectile dysfunction (ED) secondary to endothelial dysfunction. This study is a double-blind, randomized, placebo-controlled, clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback